Literature DB >> 23832130

Hypnic headache.

Dagny Holle1, Steffen Naegel, Mark Obermann.   

Abstract

BACKGROUND: Hypnic headache (HH) is a rare primary headache disorder that is characterised by strictly sleep-related headache attacks.
PURPOSE: Because of the low prevalence of this headache disorder, disease information is mainly based on case reports and small case series. This review summarises current knowledge on HH in regard to clinical presentation, pathophysiology, symptomatic causes and therapeutic options.
METHOD: We review all reported HH cases since its first description in 1988 by Raskin. Broadened diagnostic criteria were applied for patient selection that slightly deviate from the current ICHD-II criteria. Patients were allowed to describe the headache character to be other than dull. Additionally, accompanying mild trigemino-autonomic symptoms were permitted.
CONCLUSIONS: Mainly elderly patients are affected, but younger patients and even children might also suffer from HH. Headache attacks usually last between 15 and 180 minutes, but some patients report headache attacks up to 10 hours. Almost all patients report motor activity during headache attacks. Cerebral MRI and 24-hour blood pressure monitoring should be performed in the diagnostic work-up of HH. Other primary headache disorders such as migraine and cluster headache may also present with sleep-related headache attacks and should be considered first. Caffeine taken as a cup of strong coffee seems to be the best acute and prophylactic treatment option.

Entities:  

Keywords:  Hypnic headache; NREM; REM; hypothalamus; sleep

Mesh:

Year:  2013        PMID: 23832130     DOI: 10.1177/0333102413495967

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  8 in total

Review 1.  Hints on Diagnosing and Treating Headache.

Authors:  Arne May
Journal:  Dtsch Arztebl Int       Date:  2018-04-27       Impact factor: 5.594

2.  Hypnic Headache Responds to Topiramate: A Case Report and a Review of Mechanisms of Action of Therapeutic Agents.

Authors:  Hassan Kesserwani
Journal:  Cureus       Date:  2021-03-09

Review 3.  Indomethacin-responsive headaches.

Authors:  Juliana VanderPluym
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

Review 4.  Headaches of the elderly.

Authors:  Thomas P Bravo
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 6.030

Review 5.  Acute headache.

Authors:  Raeburn B Forbes
Journal:  Ulster Med J       Date:  2014-01

6.  European Headache Federation consensus on technical investigation for primary headache disorders.

Authors:  D D Mitsikostas; M Ashina; A Craven; H C Diener; P J Goadsby; M D Ferrari; C Lampl; K Paemeleire; J Pascual; A Siva; J Olesen; V Osipova; P Martelletti
Journal:  J Headache Pain       Date:  2016-02-09       Impact factor: 7.277

7.  Chronic Cluster Headache with an Atypical Presentation and Treatment Response.

Authors:  Telma Santos; Hugo Morais
Journal:  Case Rep Neurol Med       Date:  2016-12-29

Review 8.  The Role of Adenosine Signaling in Headache: A Review.

Authors:  Nathan T Fried; Melanie B Elliott; Michael L Oshinsky
Journal:  Brain Sci       Date:  2017-03-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.